|
ASF1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13797860024079E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66877622831407E-12 |
| Normal-vs-Stage2 |
1.152810E-04 |
| Normal-vs-Stage3 |
5.49840173391658E-11 |
| Normal-vs-Stage4 |
6.94190038785791E-10 |
| Stage1-vs-Stage2 |
9.204300E-03 |
| Stage1-vs-Stage3 |
7.900600E-01 |
| Stage1-vs-Stage4 |
6.382000E-01 |
| Stage2-vs-Stage3 |
2.476000E-02 |
| Stage2-vs-Stage4 |
1.421550E-02 |
| Stage3-vs-Stage4 |
5.386200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.70974345792274E-14 |
| Normal-vs-AfricanAmerican |
3.23540000002343E-06 |
| Normal-vs-Asian |
7.30200011567206E-10 |
| Caucasian-vs-AfricanAmerican |
7.560600E-01 |
| Caucasian-vs-Asian |
7.419400E-01 |
| AfricanAmerican-vs-Asian |
9.196800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.15420006885358E-10 |
| Normal-vs-Female |
1.71662684067542E-12 |
| Male-vs-Female |
6.017400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63880020664919E-12 |
| Normal-vs-Age(41-60Yrs) |
9.49950118567244E-11 |
| Normal-vs-Age(61-80Yrs) |
2.68790001367591E-09 |
| Normal-vs-Age(81-100Yrs) |
1.731940E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.316000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.021610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.200400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.392000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.258200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.679600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.588200E-02 |
| Classical-VS-Follicular |
2.156000E-03 |
| Classical-VS-Other |
6.779800E-01 |
| Classical-VS-Normal |
1.63258295771129E-12 |
| Tall-VS-Follicular |
3.789400E-04 |
| Tall-VS-Other |
4.199600E-01 |
| Tall-VS-Normal |
2.6629809468659E-12 |
| Follicular-VS-Other |
5.909000E-01 |
| Follicular-VS-Normal |
2.47019999999321E-06 |
| Other-VS-Normal |
6.800100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.09843253884401E-12 |
| Normal-vs-N1 |
4.80369966027183E-10 |
| N0-vs-N1 |
9.448200E-01 |
|
|
